Testing of mechanisms of action of rituximab and clinical results in high-risk patients with aggressive CD20+ lymphoma. Radiol Oncol [Internet]. 2007 Mar. 1 [cited 2026 Nov. 4];41(1). Available from: https://radioloncol.com/index.php/ro/article/view/1240